Barclays
FRX

Barclays’s FOREST LABORATORIES INC FRX Stock Holding History

Barclays’s Portfolio FRX Stock Details FRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-30,300
Closed -$3M – 8090
2014
Q2 		$3M Sell
30,300
-186,600
-86% -$17.4M ﹤0.01% 2224
2014
Q1 		$20M Buy
216,900
+15,600
+8% +$1.26M 0.02% 690
2013
Q4 		$12.1M Sell
201,300
-210,800
-51% -$10.6M 0.01% 1120
2013
Q3 		$17.3M Buy
412,100
+73,000
+22% +$3.17M 0.02% 762
2013
Q2 		$13.9M Buy
+339,100
New +$13.1M 0.02% 850

Other funds holding FRX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
OFG
OTA Financial Group Purchase, New York $143M AUM 16.9% 1-Year Est. Return
KRSITF
Kentucky Retirement Systems Insurance Trust Fund Frankfort, Kentucky $1.47B AUM 27.58% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $1.87B AUM 29.51% 1-Year Est. Return

Barclays's FRX Position: Q3 2014 in Review

Barclays sold out of FOREST LABORATORIES INC (FRX) in Q3 2014, closing a stake of 726,346 shares — an estimated $71.9M sold.

Barclays first reported a position in FRX in Q2 2013 and held it in 5 quarters. The position peaked at $82.4M in Q1 2014. 5 funds tracked by Wall St. Rank hold FRX as of Q3 2014.

  • Barclays reported no remaining FOREST LABORATORIES INC position as of Q3 2014 after selling out during the quarter.
  • Barclays sold 726,346 FOREST LABORATORIES INC shares in Q3 2014, an estimated $71.9M.
  • Barclays first reported a position in FOREST LABORATORIES INC in Q2 2013 and held it in 5 quarters.
  • Barclays's FOREST LABORATORIES INC position peaked at $82.4M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held FOREST LABORATORIES INC as of Q3 2014.

Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.